All News #Library
Biotech
Denovo Biopharma, Orygen Partner on DB103 Phase 2 Psychosis Trial
11 Feb 2026 //
GLOBENEWSWIRE
Denovo Licenses DB104 for TRD in Taiwan to Chuang Yi
23 Jun 2025 //
GLOBENEWSWIRE
CIRM Grants $11.8M For Glioblastoma Gene Therapy Trial
30 Apr 2024 //
PR NEWSWIRE

Market Place
Sourcing Support